首页> 外文期刊>Protein and peptide letters >Cloning, soluble expression, and production of recombinant antihypertensive peptide multimer (AHPM-2) in escherichia coli for bioactivity identification
【24h】

Cloning, soluble expression, and production of recombinant antihypertensive peptide multimer (AHPM-2) in escherichia coli for bioactivity identification

机译:大肠杆菌中抗高血压肽多聚体(AHPM-2)的克隆,可溶性表达和生产,用于生物活性鉴定

获取原文
获取原文并翻译 | 示例
           

摘要

Recombinant antihypertensive peptide multimer (AHPM-2, 8kDa/68AA), a new designed polypeptide with potential antihypertensive effect in vivo, is composed of 15 low-molecular-weight antihypertensive peptides tandemly linked up according to the restriction sites of gastrointestinal proteases. After gene optimization, the DNA fragment encoding AHPM-2 was chemically synthesized, cloned into the pET32a, and successfully expressed in E.coli, above 90% in a soluble form. After chromatographic purification, the expressed fusion protein Trx-AHPM-2 was subject to the simulated gastrointestinal digestion, and the hydrolysate showed potent ACE inhibitory activity with an IC_(50) value of 4.5±0.3 μg ml~(-1). The active fragments from the AHPM-2 were identified by UPLC-MS/MS. This method will be useful in obtaining an appreciable quantity of recombinant AHP at low cost, and the intact AHPM-2 is expected to be developed into functional food for preventing hypertension as well as for therapeutic.
机译:重组抗高血压肽多聚体(AHPM-2,8kDa / 68AA)是一种新设计的在体内具有潜在抗高血压作用的多肽,由15种低分子量抗高血压肽组成,它们根据胃肠道蛋白酶的限制性位点串联在一起。基因优化后,化学合成了编码AHPM-2的DNA片段,将其克隆到pET32a中,并成功地以90%以上的可溶性形式在大肠杆菌中表达。色谱纯化后,对表达的融合蛋白Trx-AHPM-2进行模拟胃肠消化,水解产物显示出有效的ACE抑制活性,IC_(50)值为4.5±0.3μgml〜(-1)。 AHPM-2的活性片段通过UPLC-MS / MS鉴定。该方法将有助于以低成本获得可观数量的重组AHP,并且完整的AHPM-2有望被开发为功能性食品,用于预防高血压和治疗高血压。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号